Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: The power of worldwide collaboration.

Odile A van den Heuvel | Premika S W Boedhoe | Sara Bertolin | Willem B Bruin | Clyde Francks | Iliyan Ivanov | Neda Jahanshad | Xiang-Zhen Kong | Jun Soo Kwon | Joseph O'Neill | Tomas Paus | Yash Patel | Fabrizio Piras | Lianne Schmaal | Carles Soriano-Mas | Gianfranco Spalletta | Guido A van Wingen | Je-Yeon Yun | Chris Vriend | H Blair Simpson | Daan van Rooij | Marcelo Q Hoexter | Martine Hoogman | Jan K Buitelaar | Paul Arnold | Jan C Beucke | Francesco Benedetti | Irene Bollettini | Anushree Bose | Brian P Brennan | Alessandro S De Nadai | Kate Fitzgerald | Patricia Gruner | Edna Grünblatt | Yoshiyuki Hirano | Chaim Huyser | Anthony James | Kathrin Koch | Gerd Kvale | Luisa Lazaro | Christine Lochner | Rachel Marsh | David Mataix-Cols | Pedro Morgado | Takashi Nakamae | Tomohiro Nakao | Janardhanan C Narayanaswamy | Erika Nurmi | Christopher Pittenger | Y C Janardhan Reddy | João R Sato | Noam Soreni | S Evelyn Stewart | Stephan F Taylor | David Tolin | Sophia I Thomopoulos | Dick J Veltman | Ganesan Venkatasubramanian | Susanne Walitza | Zhen Wang | Paul M Thompson | Dan J Stein | ENIGMA-OCD working group
Human brain mapping | 2022

Neuroimaging has played an important part in advancing our understanding of the neurobiology of obsessive-compulsive disorder (OCD). At the same time, neuroimaging studies of OCD have had notable limitations, including reliance on relatively small samples. International collaborative efforts to increase statistical power by combining samples from across sites have been bolstered by the ENIGMA consortium; this provides specific technical expertise for conducting multi-site analyses, as well as access to a collaborative community of neuroimaging scientists. In this article, we outline the background to, development of, and initial findings from ENIGMA's OCD working group, which currently consists of 47 samples from 34 institutes in 15 countries on 5 continents, with a total sample of 2,323 OCD patients and 2,325 healthy controls. Initial work has focused on studies of cortical thickness and subcortical volumes, structural connectivity, and brain lateralization in children, adolescents and adults with OCD, also including the study on the commonalities and distinctions across different neurodevelopment disorders. Additional work is ongoing, employing machine learning techniques. Findings to date have contributed to the development of neurobiological models of OCD, have provided an important model of global scientific collaboration, and have had a number of clinical implications. Importantly, our work has shed new light on questions about whether structural and functional alterations found in OCD reflect neurodevelopmental changes, effects of the disease process, or medication impacts. We conclude with a summary of ongoing work by ENIGMA-OCD, and a consideration of future directions for neuroimaging research on OCD within and beyond ENIGMA.

Pubmed ID: 32154629 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: R01MH081864
  • Agency: NIMH NIH HHS, United States
    Id: K23 MH082176
  • Agency: NIH HHS, United States
    Id: R01MH117601
  • Agency: NIH HHS, United States
    Id: K23 MH115206
  • Agency: Wellcome Trust, United Kingdom
  • Agency: NIMH NIH HHS, United States
    Id: R01MH117601
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH121520
  • Agency: NIMH NIH HHS, United States
    Id: R01MH085900
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001863
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH081864
  • Agency: NIMH NIH HHS, United States
    Id: R21 MH093889
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH116147
  • Agency: NIMH NIH HHS, United States
    Id: R21 MH110865
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH104648
  • Agency: NIBIB NIH HHS, United States
    Id: U54 EB020403
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH117601
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH085900
  • Agency: NIH HHS, United States
    Id: R01AG059874
  • Agency: Swiss National Science Foundation, Switzerland
    Id: 320030_130237
  • Agency: CIHR, Canada
  • Agency: NIMH NIH HHS, United States
    Id: K23 MH115206
  • Agency: NIA NIH HHS, United States
    Id: R01 AG059874

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Signed Differential Mapping (tool)

RRID:SCR_002554

Statistical method and software for conducting image- and coordinate-based meta-analysis of neuroimaging studies investigating differences in brain activity (e.g. BOLD response in fMRI, metabolism in PET) or structure (e.g. gray matter volume in VBM, voxel-based or TBSS white matter fractional anisotropy in DTI, etcetera).

View all literature mentions